Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels activated by glutamate, mediating fast excitatory synaptic transmission in the central nervous system. They are crucial for synaptic plasticity, learning, and memory. iGluRs function as tetramers, with each subunit containing an N-terminal domain (NTD), a ligand-binding domain (LBD), a transmembrane domain (TMD), and an intracellular C-terminal domain (CTD). The three main subtypes are AMPA, NMDA, and Kainate receptors, each with distinct pharmacology and ion permeabilities. iGluRs regulate numerous processes in the brain, spinal cord, and peripheral nervous system, and are implicated in various neurological diseases.
Ligand binding to the extracellular domain causes a conformational change, opening the ion channel pore and allowing the influx of cations (Na+, K+, and/or Ca2+), leading to neuronal depolarization and excitatory postsynaptic currents. NMDA receptors require both glutamate and a co-agonist (glycine or serine) binding, as well as membrane depolarization to relieve Mg2+ block.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate Receptor Ionotropic (iGluR).